Changes in anticoagulant utilization among United States nursing home residents with atrial fibrillation from 2011 to 2016
Journal of the American Heart Association May 09, 2019
Alcusky M, et al. - Researchers used a repeated cross-sectional design and investigated if direct-acting oral anticoagulant (DOAC) use has disseminated into nursing homes and increased anticoagulant use. They examined Medicare fee-for-service beneficiaries with atrial fibrillation residing in long-stay nursing homes, to estimate the point prevalence of oral anticoagulant use on July 1 and December 31 of calendar years 2011 to 2016. On December 31, 2011, an oral anticoagulant has been received by 42.3% of 33,959 residents, of whom DOACs were received by 8.6%. Standard dosages were given to half of the 8734 DOAC users, and most of these received apixaban (54.4%) or rivaroxaban (35.8%) in 2016. Overall, findings revealed the coincidence of increases in anticoagulant use with declining warfarin use and increasing DOAC use.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries